<div id="readability-page-1">03:41 PM EST, 12/23/2025 (MT Newswires) -- Health care stocks were mixed late Tuesday afternoon, with the NYSE Health Care Index fractionally higher and the State Street Health Care Select Sector SPDR ETF (XLV) easing 0.3%.The iShares Biotechnology ETF (IBB) shed 0.4%.In corporate news, Pfizer ( PFE ) shares were down 1.4% after it said Tuesday that a participant in its long-term extension trial evaluating Hympavzi in hemophilia died after serious adverse events of cerebellar infarction and cerebral hemorrhage.Novo Nordisk ( NVO ) shares jumped past 7% after it said late Monday the US Food and Drug Administration approved its Wegovy pill for weight management and to reduce the risk of major adverse cardiovascular events.Johnson &amp; Johnson ( JNJ ) has been ordered by a Baltimore jury to pay more than $1.5 billion to a single plaintiff, who claimed that the use of the pharmaceutical giant's talc-based baby powder products caused her cancer. Johnson &amp; Johnson ( JNJ ) shares were shedding 1%.RxSight ( RXST ) shares fell past 10% after the company said late Monday that chief financial officer Shelley Thunen will transition from her role. Thunen will remain with the company until the sooner of the appointment of a new CFO or Jan. 31, 2026. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

诺和诺德公司

辉瑞

强生

医疗保健股票表现参差不齐，纽约证券交易所医疗保健指数小幅上涨，而 XLV 下跌 0.3%。由于一名试验参与者的死亡，辉瑞的股价下跌了 1.4%。诺和诺德的股价在 FDA 批准其 Wegovy 药丸后上涨超过 7%。强生因一宗与滑石粉相关的诉讼被判支付 15 亿美元，导致股价下跌 1%。RxSight 在宣布首席财务官更换后股价下跌超过 10%

Sector Update: Health Care Stocks Mixed Late Afternoon

- 健康护理股走势不一，NYSE 健康护理指数小幅上涨，XLV 下跌 0.3%。  
- 辉瑞（Pfizer）股价下跌 1.4%，因一名试验参与者因严重不良事件去世。  
- 诺和诺德（Novo Nordisk）股价上涨超过 7%，因 FDA 批准其 Wegovy 药片用于体重管理。

板块更新：医疗保健类股在午后交易中表现不一